Two instruments dominate seed-stage financing: the SAFE and the priced round. Both put money in the company's bank account. Both give investors some form of equity upside. But they work very differently, and the choice between them has downstream consequences that founders often don't fully understand until a Series A is on the table and the dilution math is done for the first time.

This post explains how each instrument works, when each one makes sense, and what to watch out for.

How the SAFE Works

The SAFE — Simple Agreement for Future Equity — was developed by Y Combinator and has become the default early-stage financing document in the startup ecosystem. Its defining characteristic is simplicity: the investor gives the company money today, and in exchange receives the right to convert that money into equity at a future priced round.

No valuation is set at the time of the SAFE. No interest accrues. There is no maturity date at which the note becomes due. The investor is betting that when a priced round eventually happens, the conversion terms built into the SAFE will produce a favorable price per share.

Those conversion terms come in two forms, which may appear separately or together:

  • Valuation cap. The SAFE converts at the lower of (a) the cap and (b) the Series A price. If the cap is $5 million and the Series A values the company at $20 million, the SAFE investor converts as if the price were based on a $5 million valuation — a significant discount to the actual round price. The lower the cap, the better for the investor.
  • Discount. The SAFE converts at a percentage discount to the Series A price (commonly 15–20%). If the Series A price per share is $2.00 and the SAFE carries a 20% discount, the SAFE investor converts at $1.60 per share.

SAFEs are fast and cheap to execute. A standard YC SAFE can be documented with a single four-page agreement. No board approval is typically required. There is no need for a 409A valuation, no required stock issuance, and no immediate dilution to the cap table. For a company collecting small checks from multiple angels, this is enormously convenient.

How the Priced Round Works

A priced round is a genuine equity issuance. The company and investors agree on a pre-money valuation, shares are priced accordingly, and investors receive actual preferred stock immediately. The documents — a Stock Purchase Agreement, an Investors' Rights Agreement, a Right of First Refusal and Co-Sale Agreement, and a Voting Agreement — take more time and more legal work to negotiate and execute.

But the result is clean: investors know exactly what percentage of the company they own from day one. The cap table is updated immediately. Preferred stock comes with negotiated terms — liquidation preferences, anti-dilution protection, information rights, and potentially board representation — all spelled out in writing.

The Dilution Problem You Don't See Coming

Here is the scenario that surprises founders most often: they raise $750,000 through a series of SAFEs over 18 months — a $300,000 SAFE at a $5 million cap, a $250,000 SAFE at a $4 million cap, a $200,000 SAFE at a $6 million cap — and then they raise a Series A at a $10 million pre-money valuation.

At the moment of the Series A, all three SAFEs convert simultaneously. The conversion math depends on the cap in each SAFE. The $4 million cap SAFE converts into a larger percentage of the company than the $6 million cap SAFE, even though the dollar amounts invested were similar. Founders watching only the headline Series A valuation often do not realize how much their ownership has been compressed until the attorneys prepare the post-money cap table.

Working through a simplified example: if you issued $750,000 in SAFEs at an average cap of approximately $5 million, and your Series A is at a $10 million pre-money valuation with a 15% option pool, the SAFE holders might convert into roughly 13–16% of the company on a fully diluted basis — significantly more than founders expected when they were issuing those SAFEs at various stages.

The lesson: model the cap table before you issue SAFEs, and model it again before you close the priced round. Surprises at Series A are expensive — not just emotionally, but because a cap table that looks worse than investors expected can affect valuation negotiations.

The Post-Money SAFE: What Changed

YC updated its standard SAFE form several years ago to use post-money valuation caps rather than pre-money caps. This is an important distinction. Under a post-money SAFE, the valuation cap includes the money being raised under the SAFE — which means the dilution to the founders is locked in at the time the SAFE is signed, not at the time of conversion.

Post-money SAFEs are more predictable for investors and make it easier to calculate founder dilution upfront. But from the founder's perspective, a post-money SAFE with a $5 million cap means the investor will own a fixed percentage of the company (approximately 10% if the SAFE is $500,000) regardless of how large the subsequent priced round is. That predictability cuts both ways.

When Each Instrument Makes Sense

SAFEs make sense when:

  • You are raising from multiple angels writing small checks and speed matters.
  • The company is pre-revenue or very early stage and setting a defensible valuation is genuinely difficult.
  • You do not have the relationships or traction to attract a lead investor who will do the work of a priced round.

Priced rounds make sense when:

  • You have a lead investor writing a meaningful check ($1 million or more) who is willing to set the price.
  • The company has enough traction to support a defensible valuation that won't be embarrassing to explain at the next round.
  • Investors want board representation, pro-rata rights, or information rights — provisions that SAFEs typically do not provide.
  • You want to stop the accumulation of convertible instruments on your cap table before they become unmanageable.

What SAFEs Don't Give Investors (and Why That Matters)

Standard SAFEs do not include information rights, board seats, or pro-rata rights. For a solo angel writing a $25,000 check, this is fine. For an investor who has written a $500,000 check and is a meaningful stakeholder in the company, the lack of governance rights can become a source of friction — especially if the company goes through a difficult period before the Series A.

Some investors will negotiate for a side letter alongside the SAFE that grants information rights (typically quarterly financials and annual audited statements). This is reasonable and worth accommodating for larger checks.

The Practical Takeaway

There is no universally correct answer between a SAFE and a priced round. The right choice depends on how much you are raising, who you are raising it from, what stage the company is at, and how much legal complexity you want to take on.

What is universally correct is understanding the economics before you sign. Get a lawyer to model your cap table — including all outstanding SAFEs and their conversion scenarios — before you issue new instruments, and again before you close a priced round. The math is not intuitive, and the mistakes are expensive.